Roivant Sciences (ROIV) Payables (2021 - 2026)
Roivant Sciences (ROIV) recorded Payables of $25.08 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 117.2% from $11.55 million a year earlier and up 39.3% from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Payables (2021 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Roivant Sciences reported Payables of $18 million, down 24.0% from FY2025.
- Annual Payables has a five-year compound annual growth rate of -2.6% (FY2021 to FY2026).
- Across earlier fiscal years, Payables came in at $23.69 million in FY2025 (+68.9%), $14.03 million in FY2024 (-62.9%), $37.83 million in FY2023 (+9.4%) and $34.58 million in FY2022 (+68.3%).
- The fiscal Q1 2027 figure is the highest quarterly Payables since fiscal Q2 2025.
- On a year-over-year basis, Payables rose in two of the last eight quarters, with an average decline of 7.0%.
- Peak year-over-year performance for Payables in the last five years was growth of 117.2% in fiscal Q1 2027, against a decline of 74.3% in fiscal Q1 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $18 million (Q4 2026), $13.29 million (Q3 2026) and $15.06 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Roivant Sciences | 26.72 Bn | 27.41 Bn | 1.16 Mn | 25.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.08 Mn |
| Mar 31, 2026 | 18.00 Mn |
| Dec 31, 2025 | 13.29 Mn |
| Sep 30, 2025 | 15.06 Mn |
| Jun 30, 2025 | 11.55 Mn |
| Mar 31, 2025 | 23.69 Mn |
| Dec 31, 2024 | 23.71 Mn |
| Sep 30, 2024 | 25.13 Mn |
| Jun 30, 2024 | 27.74 Mn |
| Mar 31, 2024 | 14.03 Mn |
| Dec 31, 2023 | 35.23 Mn |
| Sep 30, 2023 | 44.12 Mn |
| Jun 30, 2023 | 50.04 Mn |
| Mar 31, 2023 | 37.83 Mn |
| Dec 31, 2022 | 48.00 Mn |
| Sep 30, 2022 | 41.36 Mn |
| Jun 30, 2022 | 194.61 Mn |
| Mar 31, 2022 | 34.58 Mn |
| Dec 31, 2021 | 24.36 Mn |
| Sep 30, 2021 | 77.16 Mn |
API Access
Roivant Sciences Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();